100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
TEST BANK Applied Pharmacology for The Dental Hygienist 9th Edition by Elena Bablenis Haveles ||Complete A+ Guide $17.99
Add to cart
Quickly navigate to
Preview
  2.  
  3. Dental Hygienist 9th Elena Bablenis Haveles
  4.  
  5. Dental Hygienist 9th Elena Bablenis Haveles

Exam (elaborations)

TEST BANK Applied Pharmacology for The Dental Hygienist 9th Edition by Elena Bablenis Haveles ||Complete A+ Guide

 0 purchase
  • Course
  • Dental Hygienist 9th Elena Bablenis Haveles
  • Institution
  • Dental Hygienist 9th Elena Bablenis Haveles

TEST BANK Applied Pharmacology for The Dental Hygienist 9th Edition by Elena Bablenis Haveles ||Complete A+ Guide

Preview 4 out of 444  pages

Document information

  • November 11, 2024
  • 444
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers

Subjects

Connected book

book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:

More summaries for

All for this textbook (43)

Written for

  • Dental Hygienist 9th Elena Bablenis Haveles
  • Dental Hygienist 9th Elena Bablenis Haveles

Seller

avatar-seller
Ascorers

Reviews received

Content preview

TEST BANK
Applied Pharmacology for The Dental Hygienist 9th
Edition by Elena Bablenis Haveles ||Complete A+
Guide

,Chapter f01: fInformation fSources, fRegulatory fAgencies, fDrug fLegislation, fand fPrescription
fWriting

Haveles: fApplied fPharmacology ffor fthe fDental fHygienist, f9th fEdition



MULTIPLE fCHOICE

1. Knowledge fof fpharmacology faids fthe fdental fprofessional fin
a. obtaining fa fpatient’s fhealth fhistory.
b. administering fdrugs fin fthe foffice.
c. handling femergency fsituations.
d. selection fof fa fnonprescription fmedication.
e. All fof fthe fabove.
ANS: f E
All fof fthe fchoices fare ftrue. fBecause fmany fof four fpatients fare fbeing ftreated fwith fdrugs, fknowledge fof
fpharmacology fhelps fin funderstanding fand finterpreting fpatients’ fresponses fto fhealth fhistory fquestions.

fKnowledge fof fthe ftherapeutic fand fadverse feffects fof fmedications fobviously fhelps fin ftheir fproper

fadministration fin fthe foffice. fEmergency fsituations fmay fbe fcaused fby fdrugs for ftreated fby fdrugs; fthus,

fknowledge fof fpharmacology fis fof fgreat fhelp, fespecially fbecause fa frapid fresponse fis fsometimes

frequired. fA fclear funderstanding fof fthe fconcepts fof fdrug faction, fdrug fhandling fby fthe fbody, fand fdrug

finteractions fwill fallow fthe fdental fpractitioner fto fmake fproper fjudgments fand fgrasp fthe fconcepts

frelevant fto fnew fdrug ftherapies fon fthe fmarket.



DIF: Application
REF: f Role fof fthe fDental fHygienist f(Medication/Health fHistory), fRole fof fthe fDental fHygienist
f(Medication fAdministration), fRole fof fthe fDental fHygienist f(Emergency fSituations), fRole fof fthe fDental

fHygienist f(Nonprescription fMedication) f| fpp. f2-3 OBJ: 1
TOP: f NBDHE, f6.0. fPharmacology

2. Which fof fthe ffollowing fstatements fis ftrue fregarding fplanning fappointments?
a. Whether for fnot fpatients fare ftaking fmedication ffor fsystemic fdiseases fis fof
little
f

consequence fin fthe fdental foffice.
b. Asthmatic fpatients fshould fhave fdental fappointments fin fthe fmorning.
c. Diabetic fpatients fusually fhave ffewer fproblems fwith fa fmorning fappointment
fcompared fwith fafternoon fappointments.

d. Both fB fand fC fare ftrue.
ANS: f D
Asthmatic fpatients fwho fexperience fdental fanxiety fshould fschedule ftheir fappointments fwhen fthey fare
fnot frushed for funder fpressure fearly fin fthe fmorning. fDiabetic fpatients fusually fhave frelatively ffewer

fproblems fwith fa fmorning fappointment. fPatients ftaking fmedication ffor fsystemic fdiseases fmay frequire

fspecial fhandling fin fthe fdental foffice.



DIF: Comprehension
REF: f Role fof fthe fDental fHygienist f(Appointment fScheduling) f| fp.
f3 fOBJ: f 1 TOP: f NBDHE, f6.0. fPharmacology

,3. Nutritional for fherbal fsupplements
a. carry fthe fU.S. fFood fand fDrug fAdministration f(FDA) fapproval ffor fdisease
f states.
b. are fnot fdrugs.
c. can fcause fadverse feffects.
d. will fnot finteract fwith fother fdrugs fthe fpatient fmay fbe ftaking.
ANS: f C
Nutritional for fherbal fsupplements fare fquite fcapable fof fcausing fadverse feffects. fThe fmajority fof
fnutritional for fherbal fsupplements fdo fnot fcarry fFDA fapproval ffor ftreating fdisease fstates. fThese

fsupplements fare fdrugs fand fcan fcause fadverse feffects fand finteract fwith fdifferent fdrugs.



DIF: Comprehension
REF: f Role fof fthe fDental fHygienist f(Nutritional for fHerbal fSupplements) f| fp.
f3 fOBJ: f 1 TOP: f NBDHE, f6.0. fPharmacology

4. Which ftype fof fdrug fname fusually fbegins fwith fa flowercase fletter?
a. Brand fname
b. Code fname
c. Generic fname
d. Trade fname
ANS: f C
Before fany fdrug fis fmarketed, fit fis fgiven fa fgeneric fname fthat fbecomes fthe f“official” fname fof fthe
fdrug. fEach fdrug fis fassigned fonly fone fgeneric fname fselected fby fthe fU.S. fAdopted fName fCouncil,

fand fthe fname fis fnot fcapitalized. fThe fbrand fname fis fequivalent fto fthe ftrade fname fand fis fcapitalized.

fAlthough fthe fbrand fname fis ftechnically fthe fname fof fthe fcompany fmarketing fthe fproduct, fthis fterm fis

foften fused finterchangeably fwith fthe ftrade fname. fThe fcode fname fis fthe finitial fterm fused fwithin fa

fpharmaceutical fcompany fto frefer fto fa fdrug fwhile fit fis fundergoing finvestigation fand fis foften fa

fcombination fof fcapital fletters fand fnumbers, fthe fletters frepresenting fan fabbreviation fof fthe fcompany

fname.



DIF: Comprehension REF: f Drug fNames f| fp.
f4 fOBJ: f 3 TOP: f NBDHE, f6.0. fPharmacology

5. A fdrug’s fgeneric fname fis fselected fby fthe
a. pharmaceutical fcompany fmanufacturing fit.
b. Food fand fDrug fAdministration f(FDA).
c. U.S. fAdopted fName fCouncil.
d. Federal fPatent fOffice.
ANS: f C
Each fdrug fis fassigned fonly fone fgeneric fname f(e.g., fibuprofen). fIt fis fselected fby fthe fU.S. fAdopted
fName fCouncil. fThe fgeneric fname fis fnot fselected fby fthe fFDA for fthe fFederal fPatent fOffice. fThe

fpharmaceutical fcompany fmanufacturing fthe fdrug fclearly fhas fan finfluence fon fthe fgeneric fname fgiven

fits fdrug, fbut fthe ffinal fdecision fis fnot fthe fcompany’s.



DIF: Recall REF: f Drug fNames f| fp. f4 OBJ:
f 3 fTOP: f NBDHE, f6.0. fPharmacology



6. Which fof fthe ffollowing fis ftrue fconcerning fgeneric fand ftrade fnames fof fdrugs?
a. A fdrug fmay fonly fhave fone fgeneric fname fand fone ftrade
f name.

, b. A fdrug fmay fonly fhave fone fgeneric fname, fbut fit fmay fhave fseveral ftrade
names.
f

c. A fdrug fmay fhave fseveral fgeneric fnames, fbut fit fmay fonly fhave fone ftrade
fname.

d. A fdrug fmay fhave fseveral fgeneric fnames fand fseveral ftrade fnames.
ANS: f B
Each fdrug fhas fonly fone fgeneric fname fbut fmay fhave fseveral ftrade fnames. fFor feach fdrug, fthere fis fonly
fone fgeneric fname. fIt fis fnot fcapitalized, fand fit fbecomes fthe f“official” fname fof fthe fdrug. fThe

fpharmaceutical fcompany fdiscovering fthe fdrug fgives fthe fdrug fa ftrade fname. fThe ftrade fname fis

fprotected fby fthe fFederal fPatent fLaw ffor f20 fyears ffrom fthe fearliest fclaimed ffiling fdate, fplus fpatent

fterm fextensions. fAlthough fthe fbrand fname fis ftechnically fthe fname fof fthe fcompany fmarketing fthe

fproduct, fit fis foften fused finterchangeably fwith fthe ftrade fname.



DIF: Comprehension REF: f Drug fNames f| fp.
f4 fOBJ: f 3 TOP: f NBDHE, f6.0. fPharmacology

7. Two fdrugs fthat fare ffound fto fbe fchemically fequivalent, fbut fnot fbiologically fequivalent
or ftherapeutically fequivalent fare fsaid fto fdiffer fin
f

a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic findex.
ANS: f C
A fpreparation fcan fbe fchemically fequivalent fyet fnot fbiologically for ftherapeutically fequivalent. fThese
fproducts fare fsaid fto fdiffer fin ftheir fbioavailability. fThe fpotency fof fa fdrug fis fa ffunction fof fthe famount

fof fdrug frequired fto fproduce fan feffect. fThe fefficacy fis fthe fmaximum fintensity fof feffect for fresponse

fthat fcan fbe fproduced fby fa fdrug. fThe ftherapeutic findex fis fthe fratio fof fthe flethal fdose ffor f50% fof fthe

fexperimental fanimals fdivided fby fthe feffective fdose ffor f50% fof fthe fexperimental fanimals. fIf fthe

fvalue fof fthe ftherapeutic findex fis fsmall, ftoxicity fis fmore flikely.



DIF: Recall REF: f Drug fNames f(Drug fSubstitution) f| fp.
f5 fOBJ: f 4 TOP: f NBDHE, f6.0. fPharmacology

8. How fmany fyears fmust fpass fafter fa fdrug fpatent fexpires fbefore fother fdrug fcompanies fcan fmarket
the fsame fcompound fas fa fgeneric fdrug?
f

a. 20 fyears
b. 17 fyears
c. 7 fyears
d. 0 fyears
ANS: f D
Once fa fdrug fpatent fexpires, fcompeting fcompanies fmay fimmediately fmarket fthe fsame fcompound fin
fgeneric fform. fThe fpharmaceutical fcompany fdiscovering fthe fdrug fgives fthe fdrug fa ftrade fname. fThe

ftrade fname fis fprotected fby fthe fFederal fPatent fLaw ffor f20 fyears ffrom fthe fearliest fclaimed ffiling fdate,

fplus fthe fpatent fterm fextensions.



DIF: Application REF: f Drug fNames f(Drug fSubstitution) f| fp.
f5 fOBJ: f 4 TOP: f NBDHE, f6.0. fPharmacology

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Ascorers. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $17.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67418 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling
$17.99
  • (0)
Add to cart
Added